Claim-Evidence Boundary
A claim-evidence boundary states exactly what a result proves and what it does not prove. It is useful for papers, Korean synthesis posts, project notes, and concept pages.
The minimal form is:
If any part is missing, the claim should be narrowed or marked to verify.
Boundary Fields
| Field | Question |
|---|---|
| Claim | What exact statement is being made? |
| Task | What input and output space does the evidence test? |
| Data | Which population, benchmark, preprocessing, and split define the examples? |
| Protocol | How were model selection, threshold choice, early stopping, and final testing separated? |
| Metric | What number supports the claim, and what does it average over? |
| Baseline | What comparison makes the result meaningful? |
| Uncertainty | Is the effect larger than seed variation, confidence interval, or measurement noise? |
| Scope | Where should the claim be expected to hold? |
Narrowing Rule
Write the broad version first, then narrow it until every word is supported.
| Broad Claim | Narrower Claim |
|---|---|
| This model generalizes to proteins. | This model improves metric on a protein-family split for benchmark . |
| This method improves docking. | This method improves pose plausibility under the reported pocket and ligand-preparation protocol. |
| This architecture is better. | This architecture improves metric under matched data, objective, and training budget. |
| This objective learns better representations. | This objective improves downstream metric under the stated frozen or fine-tuned protocol. |
| This benchmark proves real-world performance. | This benchmark supports the specific population, split, and allowed-information boundary it defines. |
Formula View
An empirical claim usually estimates a target quantity:
but reports a finite estimate:
- : target quantity the claim wants to support.
- : measured estimate.
- : evaluation unit, such as example, query, molecule, complex, pose, target, or task.
- : intended population or deployment distribution.
- : benchmark or test-set distribution actually sampled.
- : metric contribution for one unit.
The claim is only as broad as the match between and .
Molecular Modeling Checks
| Claim Type | Boundary To State |
|---|---|
| Molecule property | molecule standardization, label source, scaffold or time split, metric |
| Protein prediction | sequence identity or family split, residue indexing, structure source, metric |
| Protein-ligand complex | ligand scaffold, protein family, complex-pair split, pocket definition, coordinate source |
| Docking pose | receptor preparation, ligand state, pose RMSD rule, geometry checks, known-pocket assumption |
| Virtual screening | active/decoy construction, enrichment metric, property bias, target context |
| Generative molecule | validity, uniqueness, novelty, diversity, constraint satisfaction, filtering rule |
Use In Posts
For Korean synthesis posts, include only the boundary needed for the reader:
- What claim is being discussed?
- What evidence supports it?
- What split or benchmark limits the claim?
- Which wiki note holds the detailed metric, formula, or paper evidence?
Long evidence tables belong in Evidence table or paper notes. The post should keep the boundary readable.
Red Flags
- A random split is used to claim new-scaffold or new-protein generalization.
- A metric is reported without model-selection or threshold-selection details.
- A benchmark score is treated as deployment performance without population matching.
- A molecular result ignores standardization, assay context, or leakage.
- A small score difference is interpreted without uncertainty or paired comparison.
- A qualitative example is used to imply a broad quantitative claim.